Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2017 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 38,032 |
| Receivables | 381 |
| TOTAL | $38,645 |
| Non-Current Assets | |
| PPE Net | 4 |
| Intangibles | 1,176 |
| Other Non-Current Assets | 28 |
| TOTAL | $1,208 |
| Total Assets | $39,853 |
| Liabilities | |
| Current Liabilities | |
| Short Term Debt | 269 |
| Accounts payable and accrued liabilities | 215 |
| TOTAL | $1,145 |
| Non-Current Liabilities | |
| TOTAL | $259 |
| Total Liabilities | $1,405 |
| Shareholders' Equity | |
| Common Shares | 43,338 |
| Retained earnings | -4,974 |
| Other shareholders' equity | 85 |
| TOTAL | $38,448 |
| Total Liabilities And Equity | $39,853 |